Charles River Labs Intl buy JPMorgan Chase & Co.
Start price
10.08.23
/
50%
€198.20
Target price
10.08.24
€227.00
Performance (%)
7.06%
Price
09.05.24
€212.20
Summary
This prediction is currently active. With a performance of 7.06%, the BUY prediction by JPMorgan_Chase___Co_ for Charles River Labs Intl is trending in the right direction. This prediction currently runs until 10.08.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Charles River Labs Intl | -2.167% | -2.167% |
iShares Core DAX® | 4.094% | 4.888% |
iShares Nasdaq 100 | 1.424% | -0.445% |
iShares Nikkei 225® | -1.572% | -4.911% |
iShares S&P 500 | 1.822% | 0.776% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at JPMorgan Chase & Co. from $225.00 to $250.00. They now have an "overweight" rating on the stock.
Ratings data for CRL provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€227.80
15.02.24
15.02.24
€259.70
15.02.25
15.02.25
-6.85%
09.05.24
09.05.24
Charles River Labs Intl
Start price
Target price
Perf. (%)
€211.90
20.12.23
20.12.23
€246.65
20.12.24
20.12.24
0.14%
09.05.24
09.05.24